Travere Therapeutics Inc (TVTX) Insider Trading
Total insider buys:
- $0.00
Total insider sells:
- $18,684,763.79
Most recent insider trade:
- Feb. 4, 2026
Most active insider trader:
- Christopher R Cline
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Insider | 2,994 | $32.18 | Sell | $96,346.92 | |
| Feb. 4, 2026 | CFO | 1,745 | $32.19 | Sell | $56,171.55 | |
| Feb. 4, 2026 | Insider | 1,779 | $32.21 | Sell | $57,301.59 | |
| Feb. 3, 2026 | Insider | 7,175 | $32.12 | Sell | $230,461.00 | |
| Feb. 3, 2026 | CEO | 100,087 | $32.28 | Sell | $3,230,808.36 | |
| Feb. 3, 2026 | CAO | 4,333 | $32.12 | Sell | $139,175.96 | |
| Feb. 3, 2026 | CFO | 7,242 | $32.12 | Sell | $232,613.04 | |
| Feb. 3, 2026 | Insider | 7,310 | $32.12 | Sell | $234,797.20 | |
| Feb. 3, 2026 | Insider | 6,956 | $32.12 | Sell | $223,426.72 | |
| Feb. 3, 2026 | Insider | 12,446 | $32.87 | Sell | $409,100.02 | |
| Sept. 22, 2025 | Insider | 10,000 | $25.00 | Sell | $250,000.00 | |
| Sept. 4, 2025 | CFO | 119 | $19.71 | Sell | $2,345.49 | |
| Sept. 3, 2025 | CFO | 454 | $18.20 | Sell | $8,262.80 | |
| July 1, 2025 | Insider | 815 | $14.65 | Sell | $11,939.75 | |
| May 5, 2025 | CEO | 18,924 | $21.05 | Sell | $398,350.20 | |
| May 5, 2025 | CFO | 1,784 | $21.05 | Sell | $37,553.20 | |
| May 5, 2025 | Insider | 1,771 | $21.05 | Sell | $37,279.55 | |
| April 11, 2025 | CFO | 48 | $13.14 | Sell | $630.72 | |
| Feb. 12, 2025 | SVP | 5,200 | $23.53 | Sell | $122,356.00 | |
| Feb. 11, 2025 | Insider | 3,074 | $25.00 | Sell | $76,850.00 | |
| Feb. 11, 2025 | CAO | 54,244 | $25.00 | Sell | $1,356,100.00 | |
| Feb. 11, 2025 | CEO | 11,375 | $24.04 | Sell | $273,455.00 | |
| Feb. 6, 2025 | Director | 10,000 | $22.00 | Sell | $220,000.00 | |
| Feb. 3, 2025 | CFO | 5,192 | $20.12 | Sell | $104,463.04 | |
| Feb. 3, 2025 | SVP | 8,951 | $19.78 | Sell | $177,050.78 | |
| Feb. 3, 2025 | CEO | 50,691 | $20.21 | Sell | $1,024,465.11 | |
| Feb. 3, 2025 | CAO | 3,348 | $20.12 | Sell | $67,361.76 | |
| Feb. 3, 2025 | Insider | 4,207 | $20.12 | Sell | $84,644.84 | |
| Jan. 23, 2025 | Director | 16,000 | $20.00 | Sell | $320,000.00 | |
| Jan. 22, 2025 | CFO | 865 | $18.94 | Sell | $16,383.10 | |
| Jan. 22, 2025 | SVP | 2,437 | $19.46 | Sell | $47,424.02 | |
| Jan. 22, 2025 | CAO | 925 | $18.94 | Sell | $17,519.50 | |
| Jan. 22, 2025 | Insider | 1,584 | $18.94 | Sell | $30,000.96 | |
| Jan. 22, 2025 | CEO | 10,736 | $19.46 | Sell | $208,922.56 | |
| Jan. 6, 2025 | Insider | 440 | $18.76 | Sell | $8,254.40 | |
| Jan. 3, 2025 | Insider | 2,066 | $19.10 | Sell | $39,460.60 | |
| Dec. 26, 2024 | CAO | 15,000 | $17.22 | Sell | $258,300.00 | |
| Nov. 25, 2024 | CAO | 12,090 | $18.30 | Sell | $221,247.00 | |
| Oct. 4, 2024 | Director | 40,000 | $14.73 | Sell | $589,200.00 | |
| Sept. 30, 2024 | Director | 40,000 | $14.06 | Sell | $562,400.00 | |
| Sept. 9, 2024 | CFO | 2,490 | $11.52 | Sell | $28,684.80 | |
| Sept. 9, 2024 | CEO | 21,125 | $11.52 | Sell | $243,360.00 | |
| Sept. 9, 2024 | Insider | 2,191 | $11.52 | Sell | $25,240.32 | |
| Sept. 9, 2024 | SVP | 4,387 | $11.52 | Sell | $50,538.24 | |
| Sept. 4, 2024 | CFO | 514 | $9.51 | Sell | $4,888.14 | |
| April 11, 2024 | CFO | 54 | $6.74 | Sell | $363.96 | |
| Feb. 1, 2024 | CEO | 19,122 | $8.70 | Sell | $166,361.40 | |
| Feb. 1, 2024 | CAO | 2,820 | $8.53 | Sell | $24,054.60 | |
| Feb. 1, 2024 | Insider | 4,195 | $8.53 | Sell | $35,783.35 | |
| Feb. 1, 2024 | CFO | 3,818 | $8.53 | Sell | $32,567.54 |
Insiders are selling Travere Therapeutics Inc stock.
The insider traders at Travere Therapeutics Inc are: Christopher R Cline, Eric M Dube, Sandra Calvin, Peter Heerma, William E Rote, Jula Inrig, Elizabeth E Reed, Steve Aselage, Laura Clague, Roy D Baynes, Noah L Rosenberg, Gary A Lyons, Jeffrey A Meckler, and Noah L. Rosenberg
The most active insider trader at Travere Therapeutics Inc is Christopher R Cline with 18 trades.
Eric M Dube has sold the most Travere Therapeutics Inc stock with a total value of $10,169,276.59.
The most recent insider trade for Travere Therapeutics Inc was on Feb. 4, 2026.
The single biggest insider sell for Travere Therapeutics Inc was from Eric M Dube with a total value of $3,230,808.36 on Feb. 3, 2026.
